MedTrace Logo

Pulp Capping With Two Different Agents

NCT00812877 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 376

Last updated 2015-05-25

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if MTA or calcium hydroxide are more effective as pulp capping agents

Conditions

  • Dental Pulp Exposure

Interventions

DRUG

Mineral Trioxide Aggregate

Pulp capping agent, Mineral TrioxideAggregate

DRUG

Calcium Hydroxide

Pulp capping agent, Calcium Hydroxide

Sponsors & Collaborators

  • University of Washington

    collaborator OTHER

  • National Institute of Dental and Craniofacial Research (NIDCR)

    collaborator NIH

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Thomas Hilton, DMD, MS · NW PRECEDENT

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00812877 on ClinicalTrials.gov